Movement Alert｜Oscar Health, Inc. Falls 9.25% in Regular Trading, Strong Q2 Beat Offset by Unchanged Full-Year Guidance Triggering Profit-Taking

Market Focus08-06

On August 6, Oscar Health, Inc. declined 9.25% in regular trading, trading at $27.13/share, with turnover of $89.26 million. The stock had surged over 16% in pre-market trading before reversing sharply after the open.

The company reported Q2 EPS of $1.10, dramatically beating the analyst consensus estimate of $0.42-$0.49 and swinging from a loss of $0.89 per share in the year-ago period. Revenue reached $4.88 billion, up 70.6% year-over-year and exceeding the $4.73-$4.75 billion estimate. Total membership grew 46% to 2.963 million. Despite the strong operational performance, the company merely reaffirmed its full-year revenue guidance of $18.7 billion to $19.0 billion without an upward revision, disappointing investors who anticipated a raise given the magnitude of the Q2 beat.

The sharp intraday reversal reflects classic profit-taking dynamics, as market participants who had bid up shares aggressively in pre-market moved to lock in gains once the unchanged outlook signaled limited near-term upside catalysts.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1174464694?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 21:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174464694","market":"us","top_or_hot":-1,"title":"Movement Alert｜Oscar Health, Inc. Falls 9.25% in Regular Trading, Strong Q2 Beat Offset by Unchanged Full-Year Guidance Triggering Profit-Taking","media":"Market Focus","content":"<p><p>On August 6, Oscar Health, Inc. declined 9.25% in regular trading, trading at $27.13/share, with turnover of $89.26 million. The stock had surged over 16% in pre-market trading before reversing sharply after the open.</p><p>The company reported Q2 EPS of $1.10, dramatically beating the analyst consensus estimate of $0.42-$0.49 and swinging from a loss of $0.89 per share in the year-ago period. Revenue reached $4.88 billion, up 70.6% year-over-year and exceeding the $4.73-$4.75 billion estimate. Total membership grew 46% to 2.963 million. Despite the strong operational performance, the company merely reaffirmed its full-year revenue guidance of $18.7 billion to $19.0 billion without an upward revision, disappointing investors who anticipated a raise given the magnitude of the Q2 beat.</p><p>The sharp intraday reversal reflects classic profit-taking dynamics, as market participants who had bid up shares aggressively in pre-market moved to lock in gains once the unchanged outlook signaled limited near-term upside catalysts.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Oscar Health, Inc. Falls 9.25% in Regular Trading, Strong Q2 Beat Offset by Unchanged Full-Year Guidance Triggering Profit-Taking</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Oscar Health, Inc. Falls 9.25% in Regular Trading, Strong Q2 Beat Offset by Unchanged Full-Year Guidance Triggering Profit-Taking\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-06 21:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 6, Oscar Health, Inc. declined 9.25% in regular trading, trading at $27.13/share, with turnover of $89.26 million. The stock had surged over 16% in pre-market trading before reversing sharply after the open.</p><p>The company reported Q2 EPS of $1.10, dramatically beating the analyst consensus estimate of $0.42-$0.49 and swinging from a loss of $0.89 per share in the year-ago period. Revenue reached $4.88 billion, up 70.6% year-over-year and exceeding the $4.73-$4.75 billion estimate. Total membership grew 46% to 2.963 million. Despite the strong operational performance, the company merely reaffirmed its full-year revenue guidance of $18.7 billion to $19.0 billion without an upward revision, disappointing investors who anticipated a raise given the magnitude of the Q2 beat.</p><p>The sharp intraday reversal reflects classic profit-taking dynamics, as market participants who had bid up shares aggressively in pre-market moved to lock in gains once the unchanged outlook signaled limited near-term upside catalysts.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1174464694","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174464694","pubTimestamp":1786023623,"columns":[{"name":"Data Report","id":30,"label_key":"dataReport"}],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 6, Oscar Health, Inc. declined 9.25% in regular trading, trading at $27.13/share, with turnover of $89.26 million. The stock had surged over 16% in pre-market trading before reversing...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"走势警报|Oscar Health, Inc. 在常规交易中下跌 9.25%，第二季度的强劲表现被全年指引不变引发获利回吐所抵消","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"On August 6, Oscar Health, Inc. declined 9.25% in regular trading, trading at $27.13/share, with turnover of $89.26 million. The stock had surged over 16% in pre-market trading before reversing sharply after the open.The company reported Q2 EPS of $1.10, dramatically beating the analyst consensus estimate of $0.42-$0.49 and swinging from a loss of $0.89 per share in the year-ago period. Revenue reached $4.88 billion, up 70.6% year-over-year and exceeding the $4.73-$4.75 billion estimate. Total membership grew 46% to 2.963 million. Despite the strong operational performance, the company merely reaffirmed its full-year revenue guidance of $18.7 billion to $19.0 billion without an upward revision, disappointing investors who anticipated a raise given the magnitude of the Q2 beat.The sharp intraday reversal reflects classic profit-taking dynamics, as market participants who had bid up shares aggressively in pre-market moved to lock in gains once the unchanged outlook signaled limited near-term upside catalysts.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1174464694","isCrawlerRequest":true}